These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 27153197)
1. Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma. Cohen JB; Han X; Jemal A; Ward EM; Flowers CR Cancer; 2016 Aug; 122(15):2356-63. PubMed ID: 27153197 [TBL] [Abstract][Full Text] [Related]
2. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network. Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837 [TBL] [Abstract][Full Text] [Related]
3. Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma. Calzada O; Switchenko JM; Maly JJ; Blum KA; Grover N; Mathews S; Park SI; Gordon M; Danilov A; Epperla N; Fenske TS; Hamadani M; Flowers CR; Cohen JB Leuk Lymphoma; 2018 Dec; 59(12):2862-2870. PubMed ID: 29912594 [TBL] [Abstract][Full Text] [Related]
4. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management. Vose JM Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102 [TBL] [Abstract][Full Text] [Related]
5. Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival. Shanmugasundaram K; Goyal S; Switchenko J; Calzada O; Churnetski MC; Kolla B; Bachanova V; Gerson JN; Barta SK; Gordon MJ; Danilov AV; Grover NS; Mathews S; Burkart M; Karmali R; Sawalha Y; Hill BT; Ghosh N; Park SI; Epperla N; Bond DA; Badar T; Blum KA; Hamadani M; Fenske TS; Malecek M; Kahl BS; Martin P; Guo J; Flowers CR; Cohen JB Eur J Haematol; 2021 Sep; 107(3):301-310. PubMed ID: 33973276 [TBL] [Abstract][Full Text] [Related]
6. Management Trends and Outcomes for Stage I to II Mantle Cell Lymphoma Using the National Cancer Data Base: Ascertaining the Ideal Treatment Paradigm. Gill BS; Vargo JA; Pai SS; Balasubramani GK; Beriwal S Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):668-76. PubMed ID: 26461009 [TBL] [Abstract][Full Text] [Related]
7. Extranodal Head and Neck Mantle Cell Lymphoma: Characteristics, Treatment, and Survival. Breen CT; Chao J; Mehra S; Kohli N Ann Otol Rhinol Laryngol; 2022 Apr; 131(4):412-419. PubMed ID: 34137303 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network. Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679 [TBL] [Abstract][Full Text] [Related]
9. TCL1 expression predicts overall survival in patients with mantle cell lymphoma. Shin SJ; Roh J; Cha HJ; Choi YD; Kim JM; Min SK; Kim JE; Eom DW; Lee H; Kim HJ; Yoon DH; Suh C; Huh J Eur J Haematol; 2015 Dec; 95(6):583-94. PubMed ID: 25688912 [TBL] [Abstract][Full Text] [Related]
10. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype. Bernard M; Gressin R; Lefrère F; Drénou B; Branger B; Caulet-Maugendre S; Tass P; Brousse N; Valensi F; Milpied N; Voilat L; Sadoun A; Ghandour C; Hunault M; Leloup R; Mannone L; Hermine O; Lamy T Leukemia; 2001 Nov; 15(11):1785-91. PubMed ID: 11681422 [TBL] [Abstract][Full Text] [Related]
11. Racial and Socioeconomic Disparities in Mantle Cell Lymphoma. Shah NN; Xi Y; Liu Y; Koff JL; Flowers CR; Behera M; Cohen JB Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e312-e320. PubMed ID: 31029647 [TBL] [Abstract][Full Text] [Related]
12. The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma. Hanf M; Chiron D; de Visme S; Touzeau C; Maisonneuve H; Jardel H; Pellat-Deceunynck C; Amiot M; le Gouill S BMC Cancer; 2016 Oct; 16(1):802. PubMed ID: 27737650 [TBL] [Abstract][Full Text] [Related]
13. Association of red blood cell distribution width and outcomes in patients with mantle cell lymphoma. Miao Y; Zhou XH; Guo JJ; Sun Q; Shi K; Wu JZ; Zhu HY; Wang L; Fan L; Xu W; Li JY Cancer Med; 2019 Jun; 8(6):2751-2758. PubMed ID: 30980510 [TBL] [Abstract][Full Text] [Related]
14. Low absolute NK cell counts in peripheral blood are associated with inferior survival in patients with mantle cell lymphoma. Zhou XH; Zhang XY; Liang JH; Zhu HY; Wang L; Xia Y; Cao L; Wu W; Fan L; Li JY; Xu W Cancer Biomark; 2019; 24(4):439-447. PubMed ID: 30932881 [TBL] [Abstract][Full Text] [Related]
15. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management. Vose JM Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091 [TBL] [Abstract][Full Text] [Related]
16. Effect of radiotherapy on the survival of patients with stage I and stage II mantle cell lymphoma: analysis of the Surveillance, Epidemiology and End Results database. Guru Murthy GS; Venkitachalam R; Mehta P Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S90-5. PubMed ID: 25486963 [TBL] [Abstract][Full Text] [Related]
17. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management. Vose JM Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436 [TBL] [Abstract][Full Text] [Related]
18. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features. Rasmussen PK Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159 [TBL] [Abstract][Full Text] [Related]
19. Long-term outcome for patients with early stage marginal zone lymphoma and mantle cell lymphoma. Barzenje DA; Holte H; Fosså A; Ghanima W; Liestøl K; Delabie J; Kolstad A Leuk Lymphoma; 2017 Mar; 58(3):623-632. PubMed ID: 27389974 [TBL] [Abstract][Full Text] [Related]